Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.54 |
| ▸ | TP53 | P04637 | 1/20 | 0.52 |
| ▸ | SRD5A2 | P31213 | 2/20 | 0.46 |
| ▸ | PARP1 | P09874 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.45 |
| ▸ | CA1 | P00915 | 2/20 | 0.44 |
| ▸ | CA2 | P00918 | 2/20 | 0.44 |
| ▸ | CA12 | O43570 | 1/20 | 0.44 |
| ▸ | CA3 | P07451 | 1/20 | 0.44 |
| ▸ | TYR | P14679 | 1/20 | 0.44 |
| ▸ | DRD1 | P21728 | 1/20 | 0.44 |
| ▸ | CA4 | P22748 | 1/20 | 0.44 |
| ▸ | CA6 | P23280 | 1/20 | 0.44 |
| ▸ | CA5A | P35218 | 1/20 | 0.44 |
| ▸ | CA7 | P43166 | 1/20 | 0.44 |
| ▸ | CA9 | Q16790 | 1/20 | 0.44 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.44 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13969751 | 0.89 | ALDH1A1 (0.46) | TSHRTP53SRD5A2PARP1TDP1 | |
| SCHEMBL25680334 | 0.83 | TSHR (0.48) | TSHRTP53SRD5A2TDP1CA1 | |
| SCHEMBL14391557 | 0.82 | USP2 (0.44) | TSHRTP53SRD5A2TDP1HPGD | |
| SCHEMBL12385477 | 0.81 | TSHR (0.46) | TSHRPARP1ALDH1A1SMN1; SMN2LTA4H | |
| SCHEMBL2619374 | 0.81 | LMNA (0.49) | TSHRPARP1HPGDALDH1A1SMN1; SMN2 | |
| SCHEMBL14966664 | 0.79 | PRKAG1 (0.47) | TSHRTP53HPGDALDH1A1 | |
| SCHEMBL46155 | 0.78 | TSHR (0.72) | TSHRPARP1 | |
| SCHEMBL730751 | 0.77 | PRKAG1 (0.48) | TSHRTP53SRD5A2HPGD | |
| Bicarbonate SCHEMBL26676303 | 0.77 | TSHR (0.81) | TSHRPARP1ALDH1A1 | |
| Terephthalic Acid SCHEMBL28687 | 0.77 | TSHR (0.57) | TSHRTP53SRD5A2TDP1CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025041533-A1 | SEMICONDUCTOR SUBSTRATE PRODUCTION METHOD AND FILM-FORMING COMPOSITION | JSR株式会社 | 2025-02-27 | — | — | WO | disclosed |
| US-8445179-B2 | Method for treating a lithographic printing plate | AGFA GRAPHICS NV (BE) | 2013-05-21 | — | — | US | disclosed |
| US-8445179-B2 | Method for treating a lithographic printing plate | AGFA GRAPHICS NV (BE) | 2013-05-21 | — | — | US | disclosed |
| US-20100137180-A1 | METHOD FOR TREATING A LITHOGRAPHIC PRINTING PLATE | AGFA GRAPHICS NV (BE) | 2010-06-03 | — | — | US | disclosed |
| US-20090275583-A1 | ANTIVIRAL COMPOUNDS AND USE THEREOF | MYRIAD GENETICS, INCORPORATED (US) | 2009-11-05 | — | — | US | disclosed |
| US-20090275583-A1 | ANTIVIRAL COMPOUNDS AND USE THEREOF | MYRIAD GENETICS, INCORPORATED (US) | 2009-11-05 | — | — | US | disclosed |
| US-20090275583-A1 | ANTIVIRAL COMPOUNDS AND USE THEREOF | MYRIAD GENETICS, INCORPORATED (US) | 2009-11-05 | — | — | US | disclosed |
| WO-2008152028-A1 | A METHOD FOR TREATING A LITHOGRAPHIC PRINTING PLATE | AGFA GRAPHICS NV (BE) | 2008-12-18 | — | — | WO | disclosed |
| WO-2008127364-A2 | ANTIVIRAL COMPOUNDS AND USE THEREOF | MYRIAD GENETICS, INC. (US) | 2008-10-23 | — | — | WO | disclosed |
| US-20070009537-A1 | Antimicrobial activity of antibodies producing reactive oxygen species | WENTWORTH PAUL | 2007-01-11 | — | — | US | disclosed |
| US-20060292076-A1 | Antimicrobial mediated ozone generation | SCRIPPS RESEARCH INSTITUTE, THE | 2006-12-28 | — | — | US | disclosed |
| EP-1563062-A1 | ANTIMICROBIAL ACTIVITY OF ANTIBODIES PRODUCING REACTIVE OXYGEN SPECIES | Novartis AG (CH) | 2005-08-17 | — | — | EP | disclosed |
| EP-1563299-A2 | ANTIBODY- OR NEUTROPHIL-MEDIATED OZONE GENERATION | Novartis AG (CH) | 2005-08-17 | — | — | EP | disclosed |
| US-20050129680-A1 | Antimicrobial activity of antibodies | SCRIPPS RESEARCH INSTITUTE, THE | 2005-06-16 | — | — | US | disclosed |
| US-20040157280-A1 | Antibody mediated ozone generation | SCRIPPS RESEARCH INSTITUTE, THE | 2004-08-12 | — | — | US | disclosed |
| WO-2004044191-A1 | ANTIMICROBIAL ACTIVITY OF ANTIBODIES PRODUCING REACTIVE OXYGEN SPECIES | NOVARTIS AG (CH) | 2004-05-27 | — | — | WO | disclosed |
| WO-2004044582-A2 | ANTIBODY- OR NEUTROPHIL-MEDIATED OZONE GENERATION | NOVARTIS AG (CH) | 2004-05-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060292076-A1 | Antimicrobial mediated ozone generation | MPO, LPO, NOX4 | TSHR 3102/4885TP53 3280/4885SRD5A2 2575/4885 |
| US-20070009537-A1 | Antimicrobial activity of antibodies producing reactive oxygen species | MPO, LPO, CYBB | TSHR 3598/4885TP53 2806/4885SRD5A2 4494/4885 |
| US-20050129680-A1 | Antimicrobial activity of antibodies | MPO, PRDX3, LPO | TSHR 3758/4885TP53 2869/4885SRD5A2 4669/4885 |
| US-20040157280-A1 | Antibody mediated ozone generation | MPO, NOX5, NOX4 | TSHR 2162/4885TP53 2224/4885SRD5A2 2369/4885 |
| US-20090275583-A1 | ANTIVIRAL COMPOUNDS AND USE THEREOF | MAVS, ZC3HAV1, EIF2AK2 | TSHR 4811/4885TP53 772/4885SRD5A2 2380/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.